🦊/Investors

AbbVie2020 Investments

2 investments dated 2020 · listed companies and verified rows first · show all

Entheraentherapharmaceuticals.cominSeries A · Jul 2020 · $33M

Enthera Srl is a privately held pharmaceutical company founded in 2016 and based in Milan, Italy.

BiotechHealthtechMilan, IT

Co-investorsSofinnova PartnersIndaco Venture PartnersRoche Venture FundJDRF T1D Fund

Nitrase Therapeuticsnitrasetx.cominSeries A · Apr 2020 · $38M

Nitrase Therapeutics is a clinical-stage biopharmaceutical company using its NITROME platform to develop therapeutics based on nitrases, a class of enzymes it discovered that drive protein nitration.

BiotechHealthtechLongevity

Irene Griswold-Prenner(Founder & Chief Executive Officer)in

Co-investorsMission BiocapitalSofinnova PartnersDementia Discovery FundMission Bay Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.